• What We Do
  • Who We Are
  • Simulations
  • Presentations & Research
  • Contact Us
  • White Paper
  • Disclaimer
  • Industry Sector
  • Global Region
  • Exchange Traded Funds
  • Major Funds - Holding
  • Tutorial
  • Best Risk Adjusted
  • Worst Risk Adjusted
  • Best Expected
  • Worst Expected
  • Sector Ranking
  • Dividend
  • REIT's
  • Leverage Risk
  • Convertible Bonds
  • Investment Grade
  • High Yield
  • ADR
  • Small Caps
Rational Investing
  • About Usarrow_drop_down
  • Coveragearrow_drop_down
  • Returnsarrow_drop_down
  • Productarrow_drop_down


Drug Manufacturers - Other

       Total Market Capitalization of All Firms 109486 mm             
       Average Market Capitalization 27372 mm       
       Average Market to Model Ratio Weighted by Log of Market Cap 0.98       
       Standard Deviation of MM Ratio 0       
       Average Beta 1.17       
       Average EV To Revenue 5.74       
       Average Price To Free Cash Flow 6.25       

TickerCompany NameMarket To ModelMarket Cap ($ mm)EV to RevenuePrice To FCF% GrowthBetaAs Of
BAYN.DEBAYER AG1.177,9203.8-2.2-91.04Jun 18
BMRNBiomarin Pharmaceutical Inc.1.118,08712.3-175.1191.67Jun 18
UTHRUnited Therapeutics Corp1.15,3403.18.121.18Jun 18
VRXValeant Pharmaceuticals Intern0.68,1403.84.450.78Mar 18
Standard Value | About us | Contact us     Copyright © 2003-2018 Rational Investing LLC ® | All Rights Reserved